Medication info
Dualsaltan Tablet 40/5mg

Dualsaltan Tablet 40/5mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
CTC Bio, Co., Ltd.
Appearance
Biconvex, oval-shaped double tablet of white and light blue color
Packaging
30 tablets/PTP [30 tablets (10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 201605743 · Approved 2016.09.30 · Insurance code 669502090

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medication may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
CTC Bio, Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication helps effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medication may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Additionally, patients who are allergic to the active ingredients or related components of this medication, those with severe liver impairment, hypotension, or severe cardiovascular diseases should not use it. Patients with compromised liver function or gastrointestinal disorders should exercise special caution when using this medication, and patients with reduced kidney function should consult a physician before taking it. This medication lowers blood pressure, which may result in symptoms of hypotension, and side effects such as dizziness and peripheral edema may occur frequently. There is a risk of hyperkalemia, meaning elevated potassium levels in the blood, so caution is needed when taking potassium supplements or potassium-rich foods. There may be interactions when taken with other medications, so it is essential to consult healthcare providers, especially when combined with digoxin, lithium, warfarin, or nonsteroidal anti-inflammatory drugs. This medication is not recommended for breastfeeding women, and dosage adjustments and caution are necessary when administering it to children or the elderly. In case of overdose, severe hypotension or cardiac issues may occur, requiring immediate medical attention, and it should be stored out of the reach of children.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 110 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendinopathy
  • renal impairment
  • urination disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • vasculitis
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • position-related dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it must be stored in a container that blocks light. Additionally, it is essential to maintain a temperature between 1 to 30 degrees Celsius while storing the medication to preserve its effectiveness.

Appearance and packaging

Appearance

Biconvex, oval-shaped double tablet of white and light blue color

Package unit

30 tablets/PTP [30 tablets (10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.